Associate Director, Forecasting, HIV Prevention Integrated Insights at Gilead Sciences

Foster City, California, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biopharmaceuticals, Healthcare, PharmaceuticalsIndustries

Requirements

Broad and deep skill set including functional expertise, therapeutic area knowledge (HIV PrEP), communication skills, leadership and influencing, and executive presence
Ability to drive success across key stakeholders including business unit, brand and managed markets marketing leads, peer functional leads within Commercial Operations, Finance, Manufacturing, and executive leadership

Responsibilities

Support demand forecasting across brands in the US HIV PrEP business (including daily and long-acting oral(s) and long-acting injectable(s)) as well as monthly Actual vs Forecast (AvF) reporting
Support Gilead’s quarterly Latest Estimate (LE) forecasting for US HIV PrEP, including developing forecast scenario analyses, highlighting key risks and opportunities to characterize forecast uncertainties and critical drivers for executive leadership
Develop forecast scenario analyses, including key risks and opportunities, to characterize forecast uncertainties and key drivers for executive leadership
Support the preparation of the quarterly CCO Binder and earnings deliverables for HIV PrEP with the Executive Director
Analyze secondary data sources (script data like IQVIA, audit data like Ipsos, epidemiology data like NHANES, claims data, etc.) to glean insights, understand implications for the business, inform strategies, and make actionable recommendations
Collaborate within HIV Integrated Insights on key forecast inputs, including market research commercial analytics, and with cross-functional partners, including US sales analytics/field-force assumptions and Global forecasting and analytics colleagues
Regularly communicate with strategic partners to report analytical findings and projections related to forecasting, inventory management, and essential performance metrics/diagnostics
Lead performance reporting and diagnostics, including design and implementation of HQ facing dashboard

Skills

Key technologies and capabilities for this role

ForecastingHIV PrEPPharmaceutical ForecastingMarket AnalysisProduct LaunchPortfolio ManagementBiopharmaceuticals

Questions & Answers

Common questions about this position

What is the location for this position?

The position is based in Foster City, CA.

What is the salary range for this role?

This information is not specified in the job description.

What are the key skills required for this role?

The role requires functional expertise, therapeutic area knowledge, communication skills, leadership and influencing, and executive presence.

What is the company culture like at Gilead?

Gilead emphasizes collaboration, determination, a relentless drive to make a difference, and creating an environment where every employee feels included, developed, and empowered.

Who does this role report to?

This role reports to the Senior Director of US HIV Prevention Integrated Insights.

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters

1987Year Founded

$15,873.6MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Paid family time off and paid parental time off

Generous 401(k) contribution matching

Comprehensive medical plans that cover both physical and mental healthcare

Global Wellbeing Reimbursement

Time Off

Global Volunteer Day

Giving Together Program

Employee Support Programs

Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.

Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.

Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.

Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.

Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.

Investment in digital health technologies enhances Gilead's R&D and patient engagement.

Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI

Try Jobo Free